The Nasal Flu Vaccine Is Set to Come Back Next Year. Here ’s What to Know About It
After a two-year hiatus, the nasal flu vaccine is set to return to doctors’ offices next year. The Advisory Committee on Immunization Practices (ACIP) voted 12 to 2 on Wednesday to return the nasal spray to the CDC’s list of recommended vaccines for the 2018-2019 flu season. Pending final approval from the CDC director, the vote would greenlight the spray for widespread use and compel insurance companies to cover it. The committee stopped short of explicitly recommending the nasal spray, however, and will instead let providers and patients decide if they’ll use it instead of traditional flu shots. There is one catch. Even though this year’s flu season is still in full swing, many providers have already purchased their supplies for the next one, STAT reports — so it may be too late for the spray, which is sold under the brand name FluMist, to make much of an impact next year. Here’s what to know about the nasal flu vaccine. How does the nasal flu vaccine work? Unlike traditional flu shots, which do not contain live influenza virus, FluMist delivers a dose of influenza that helps the body mount an immune response, but is weakened to the point that it won’t cause infection, explains CDC Medical Officer Dr. Lisa Grohskopf. And because FluMist is administered nasally, it may cut off disease transmission at the source, Grohskopf says. “One of the main mechanisms through which flu is thought to be spread is though respiratory droplets...
Publication date: Available online 21 February 2019Source: CellAuthor(s): Jiang Dai, Yi-Jiao Huang, Xinhua He, Ming Zhao, Xinzheng Wang, Zhao-Shan Liu, Wen Xue, Hong Cai, Xiao-Yan Zhan, Shao-Yi Huang, Kun He, Hongxia Wang, Na Wang, Zhihong Sang, Tingting Li, Qiu-Ying Han, Jie Mao, Xinwei Diao, Nan Song, Yuan ChenSummaryThe presence of DNA in the cytoplasm is normally a sign of microbial infections and is quickly detected by cyclic GMP-AMP synthase (cGAS) to elicit anti-infection immune responses. However, chronic activation of cGAS by self-DNA leads to severe autoimmune diseases for which no effective treatment is availabl...
Since the beginning of the year, more than 160 people have contracted the virus, which was spread through a religious group and a Valentine ’ s Day gift fair.
Individuals with a 47,XXY karyotype usually present with a male phenotype due to the additional Y chromosome. In this paper, we describe a 47,XXY female who was pregnant with a fetus of the same karyotype based on chromosome analysis of amniotic fluid cells. Further analysis of her Y chromosome indicated that the additional Y chromosome contains noSRYgene on the short arm but carries the azoospermia factor region on the long arm, including azoospermia factor a, b and c (AZFa, AZFb, AZFc). This region may influence her female phenotype. Fertile females with a 47,XXY karyotype and loss ofSRY are extremely rare. This paper is...
Are early safety monitoring findings for recombinant zoster vaccine (Shingrix) consistent with prelicensure clinical trial data?Morbidity &Mortality Weekly Report
1) To determine the effects of aging on the pelvic floor in the absence of pregnancy and childbirth-related changes. 2) Test the hypothesis that aging leads to descent of the pelvic floor structures.
To illustrate technique for the planned total laparoscopic hysterectomy of a morbidly obese patient with a cesarean scar ectopic pregnancy.
To demonstrate a minimally invasive robot-assisted technique to resect a cesarean scar ectopic pregnancy also involving the cervix and subsequent metroplasty.
Cornual ectopic pregnancy (CEP) is a rare and makes up only 2-4% of ectopic pregnancies. This video describes a case of CEP that was successfully treated with a laparo-endoscopic single-site (LESS) wedge resection of the uterus.
To evaluate peri-operative clinical results as well as fertility and perinatal outcomes of women after laparoscopic cornual resection for interstitial pregnancy.
More News: Allergy | Allergy & Immunology | Aspirin | AstraZeneca | Children | Flu Pandemic | H1N1 | Health | Influenza | Influenza Vaccine | Insurance | Insurers | Learning | Pandemics | Pregnancy | Respiratory Medicine | Science | Study | Swine Flu | Swine Flu (H1N1) Vaccine | Universities & Medical Training | Vaccines | Women